Type 2 Diabetes: High-Yield Revision for MRCP, UKMLA and MSRA (2026)
High-yield type 2 diabetes revision for MRCP, UKMLA and MSRA — diagnosis, individualised HbA1c targets, the cardiorenal-first treatment shift with SGLT2 inhibitors, complications, ...
Read Insight